Main
cancer, death, coronavirus disease 2019
CANCER, CORONAVIRUS DISEASE 2019
The coronavirus disease 2019 (COVID-19)-associated risk of death is particularly high for patients with hematologic or solid cancerFew therapies improve outcomes in severe COVID-19 with impaired oxygenationClinical trials on convalescent plasma therapy for COVID-19 have been mostly negativeHere, we performed a randomized controlled clinical trial with convalescent/vaccinated plasma in high-risk patients, including patients with cancer with severe COVID-19, and analyzed the association between plasma therapy and the response of neutralizing antibody titers in plasma recipients.